Old | New | Differences | |
---|---|---|---|
1 | 1 | ||
2 | 2 | ||
3 | + | ENGR. H. A. to ENGR. S. B. NO. 1943 Page 1 1 | |
4 | + | 2 | |
5 | + | 3 | |
6 | + | 4 | |
7 | + | 5 | |
8 | + | 6 | |
9 | + | 7 | |
10 | + | 8 | |
11 | + | 9 | |
12 | + | 10 | |
13 | + | 11 | |
14 | + | 12 | |
15 | + | 13 | |
16 | + | 14 | |
17 | + | 15 | |
18 | + | 16 | |
19 | + | 17 | |
20 | + | 18 | |
21 | + | 19 | |
22 | + | 20 | |
23 | + | 21 | |
24 | + | 22 | |
25 | + | 23 | |
26 | + | 24 | |
3 | 27 | ||
4 | - | ||
5 | - | An Act | |
6 | - | ENROLLED SENATE | |
7 | - | BILL NO. 1943 By: Paxton of the Senate | |
28 | + | ENGROSSED HOUSE AMENDME NT | |
29 | + | TO | |
30 | + | ENGROSSED SENATE BILL NO . 1943 By: Paxton of the Senate | |
8 | 31 | ||
9 | 32 | and | |
10 | 33 | ||
11 | 34 | Pfeiffer of the House | |
35 | + | ||
36 | + | ||
12 | 37 | ||
13 | 38 | ||
14 | 39 | ||
15 | 40 | An Act relating to the Uniform Controlled Dangerous | |
16 | 41 | Substances Act; amending 63 O.S. 2021, Section 2 -302, | |
17 | 42 | as amended by Section 1, Chapter 103, O.S.L. 2023 (63 | |
18 | 43 | O.S. Supp. 2023, Section 2 -302), which relates to | |
19 | 44 | registration requirements; setting expiration of | |
20 | 45 | registration and requirement for application | |
21 | 46 | annually; requiring certain disclosure at | |
22 | 47 | application; providing exception; prohibi ting | |
23 | 48 | transfer of registration; a mending 63 O.S. 2021, | |
24 | 49 | Section 2-303, as amended by Section 1, Chapter 31, | |
25 | 50 | 1st Extraordinary Session, O.S.L. 2023 (63 O.S. Supp. | |
26 | 51 | 2023, Section 2-303), which relates to registration; | |
27 | 52 | removing ability for persons to be initiall y | |
28 | 53 | permitted and certain fees ass ociated with | |
29 | 54 | registration; providi ng for promulgation of rules; | |
30 | 55 | updating statutory language; and providing an | |
31 | 56 | effective date. | |
32 | 57 | ||
33 | 58 | ||
34 | 59 | ||
35 | - | SUBJECT: Registration procedures for controlled dangerous | |
36 | - | substances | |
60 | + | AMENDMENT NO. 1. Strike the title, enacting clause, and entire bill | |
61 | + | and insert: | |
62 | + | ||
63 | + | ||
64 | + | "An Act relating to the Uniform Controlled Dangerous | |
65 | + | Substances Act; amending 63 O.S. 2021, Section 2 -302, | |
66 | + | as amended by Section 1, Chapter 103, O.S.L. 2023 (63 | |
67 | + | O.S. Supp. 2023, Section 2 -302), which relates to | |
68 | + | registration requirements; setting expiration of | |
69 | + | registration and requirement for application | |
70 | + | annually; requiring certain disclosure at | |
71 | + | application; providing exception; prohibiting | |
72 | + | transfer of registration; amending 63 O.S. 2021, | |
73 | + | Section 2-303, as amended by Section 1, Chapter 31, | |
74 | + | 1st Extraordinary Session, O.S .L. 2023 (63 O.S. Supp. | |
75 | + | ||
76 | + | ENGR. H. A. to ENGR. S. B. NO. 1943 Page 2 1 | |
77 | + | 2 | |
78 | + | 3 | |
79 | + | 4 | |
80 | + | 5 | |
81 | + | 6 | |
82 | + | 7 | |
83 | + | 8 | |
84 | + | 9 | |
85 | + | 10 | |
86 | + | 11 | |
87 | + | 12 | |
88 | + | 13 | |
89 | + | 14 | |
90 | + | 15 | |
91 | + | 16 | |
92 | + | 17 | |
93 | + | 18 | |
94 | + | 19 | |
95 | + | 20 | |
96 | + | 21 | |
97 | + | 22 | |
98 | + | 23 | |
99 | + | 24 | |
100 | + | ||
101 | + | 2023, Section 2-303), which relates to registration; | |
102 | + | removing ability for persons to be initially | |
103 | + | permitted and certain fees associated with | |
104 | + | registration; providing for promulgation of rules; | |
105 | + | updating statutory language; and providi ng an | |
106 | + | effective date. | |
107 | + | ||
108 | + | ||
109 | + | ||
37 | 110 | ||
38 | 111 | BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: | |
39 | - | ||
40 | 112 | SECTION 1. AMENDATORY 63 O.S. 2021, Section 2 -302, as | |
41 | 113 | amended by Section 1, Chapter 103, O.S.L. 2023 (63 O.S. Supp. 2023, | |
42 | 114 | Section 2-302), is amended to read as follows: | |
115 | + | Section 2-302. A. Every person who manufactures, distributes, | |
116 | + | dispenses, prescribes, administers or uses for scientific purposes | |
117 | + | any controlled dangerous substance within or into this state, or who | |
118 | + | proposes to engage in the manufacture , distribution, dispensing, | |
119 | + | prescribing, administering or use for scientific purposes of any | |
120 | + | controlled dangerous substance within or into this state shall | |
121 | + | obtain a registration issued by the Director of the Oklahoma State | |
122 | + | Bureau of Narcotics and Dangerous Drugs Control, in accordance with | |
123 | + | rules promulgated by the Director. Persons registered by the | |
124 | + | Director under Section 2 -101 et seq. of this title to manufacture, | |
125 | + | distribute, dispense or conduct research with controlled dangerous | |
126 | + | substances may possess, m anufacture, distribute, dispense or cond uct | |
127 | + | research with those substances to the extent authorized by their | |
128 | + | registration and in conformity with the other provisions of the | |
129 | + | Uniform Controlled Dangerous Substances Act. Every wholesaler, | |
43 | 130 | ||
131 | + | ENGR. H. A. to ENGR. S. B. NO. 1943 Page 3 1 | |
132 | + | 2 | |
133 | + | 3 | |
134 | + | 4 | |
135 | + | 5 | |
136 | + | 6 | |
137 | + | 7 | |
138 | + | 8 | |
139 | + | 9 | |
140 | + | 10 | |
141 | + | 11 | |
142 | + | 12 | |
143 | + | 13 | |
144 | + | 14 | |
145 | + | 15 | |
146 | + | 16 | |
147 | + | 17 | |
148 | + | 18 | |
149 | + | 19 | |
150 | + | 20 | |
151 | + | 21 | |
152 | + | 22 | |
153 | + | 23 | |
154 | + | 24 | |
155 | + | ||
156 | + | manufacturer or distributor of any drug product containing | |
157 | + | pseudoephedrine or phenylpropanolamine, or their salts, isomers or | |
158 | + | salts of isomers, shall obtain a registration issued by the Director | |
159 | + | of the Oklahoma State Bureau of Narcotics and Dangerous Drugs | |
160 | + | Control in accordance with rules promulgated by the Direct or and as | |
161 | + | provided for in Section 2-332 of this title. Any person who | |
162 | + | manufactures, distributes, dispenses, prescribes, administers or | |
163 | + | uses for scientific purposes any controlled dangerous substances | |
164 | + | within or into this state without first obtaining a reg istration | |
165 | + | issued by the Director of the Oklahoma State Bureau of Narcotics and | |
166 | + | Dangerous Drugs Control shall be subject to the same statutory and | |
167 | + | administrative jurisdiction of the Director as if that person were | |
168 | + | an applicant or registrant. | |
169 | + | B. Out-of-state pharmaceutical suppliers who provide controlled | |
170 | + | dangerous substances to individuals within this state shall obtain a | |
171 | + | registration issued by the Director of the Oklahoma State Bureau of | |
172 | + | Narcotics and Dangerous Drugs Control, in accordance with rules | |
173 | + | promulgated by the Director. This provision shall also apply to | |
174 | + | wholesale distributors who distribute controlled dangerous | |
175 | + | substances to pharmacies or other entities registered within this | |
176 | + | state in accordance with rules promulgated by the Director. | |
177 | + | C. Every person who owns in whole or in part a public or | |
178 | + | private medical facility for which a majority of patients are issued | |
179 | + | on a reoccurring monthly basis a prescription for opioids, | |
180 | + | ||
181 | + | ENGR. H. A. to ENGR. S. B. NO. 1943 Page 4 1 | |
182 | + | 2 | |
183 | + | 3 | |
184 | + | 4 | |
185 | + | 5 | |
186 | + | 6 | |
187 | + | 7 | |
188 | + | 8 | |
189 | + | 9 | |
190 | + | 10 | |
191 | + | 11 | |
192 | + | 12 | |
193 | + | 13 | |
194 | + | 14 | |
195 | + | 15 | |
196 | + | 16 | |
197 | + | 17 | |
198 | + | 18 | |
199 | + | 19 | |
200 | + | 20 | |
201 | + | 21 | |
202 | + | 22 | |
203 | + | 23 | |
204 | + | 24 | |
205 | + | ||
206 | + | benzodiazepines, barbiturates or carisopr odol, but not including | |
207 | + | buprenorphine with naloxone or buprenorphine as used for medication- | |
208 | + | assisted treatment services, shall obtain a registration issued by | |
209 | + | the Director of the Oklahoma State Bureau of Narcotics and Dangerous | |
210 | + | Drugs Control. | |
211 | + | D. Every manufacturer and distributor required to re gister | |
212 | + | under the provisions of this section shall provide all data required | |
213 | + | pursuant to 21 U.S.C., Section 827(d)(1) on a monthly basis to the | |
214 | + | Oklahoma State Bureau of Narcotics and Dangerous Drugs Control. | |
215 | + | Controlled dangerous substances in Schedule I sh all be reported in | |
216 | + | accordance with rules promulgated by the Director. Reporting of | |
217 | + | controlled dangerous substances pursuant to 21 U.S.C., Section | |
218 | + | 827(d)(1) shall include, but not be limited to: | |
219 | + | 1. The manufacturer’ s or distributor’s name, address, phone | |
220 | + | number, DEA registration number and controlled dangerous substance | |
221 | + | registration number issued by the Bureau; | |
222 | + | 2. The name, address and DEA registration number of the entity | |
223 | + | to whom the controlled dangerous substance was sold; | |
224 | + | 3. The date of the sale of th e controlled dangerous substance; | |
225 | + | 4. The name and National Drug Code of the controlled dangerous | |
226 | + | substance sold; and | |
227 | + | 5. The number of containers and the strength and quantity of | |
228 | + | controlled dangerous substances in e ach container sold. | |
229 | + | ||
230 | + | ENGR. H. A. to ENGR. S. B. NO. 1943 Page 5 1 | |
231 | + | 2 | |
232 | + | 3 | |
233 | + | 4 | |
234 | + | 5 | |
235 | + | 6 | |
236 | + | 7 | |
237 | + | 8 | |
238 | + | 9 | |
239 | + | 10 | |
240 | + | 11 | |
241 | + | 12 | |
242 | + | 13 | |
243 | + | 14 | |
244 | + | 15 | |
245 | + | 16 | |
246 | + | 17 | |
247 | + | 18 | |
248 | + | 19 | |
249 | + | 20 | |
250 | + | 21 | |
251 | + | 22 | |
252 | + | 23 | |
253 | + | 24 | |
254 | + | ||
255 | + | E. The information maintained and provided pursuant to | |
256 | + | subsection D of this section shall be confidential and not open to | |
257 | + | the public. Access to the information shall, at the discretion of | |
258 | + | the Director, be limited to: | |
259 | + | 1. Peace officers certified pursuant to the provisions o f | |
260 | + | Section 3311 of Title 70 of the Oklahoma Statutes who are employed | |
261 | + | as investigative agents of the Oklahoma State Bureau of Narcotics | |
262 | + | and Dangerous Drugs Control or the Office of the Attorney General; | |
263 | + | 2. The United States Drug Enforcement Administration Diversion | |
264 | + | Group Supervisor; and | |
265 | + | 3. A multicounty grand jury properly convened pursuant to the | |
266 | + | provisions of the Multicounty Grand Jury Act. | |
267 | + | F. Manufacturers, distributors, home care agencies, hospices, | |
268 | + | home care services, medical facility owners referred to in | |
269 | + | subsection C of this section and scientific researchers shall obtain | |
270 | + | a registration annually. Other practitioners shall obtain a | |
271 | + | registration for a period to be determined by the Director that will | |
272 | + | be for a period not less than one (1) year nor mor e than three (3) | |
273 | + | years. | |
274 | + | G. Every trainer or handler of a canine controlled dangerous | |
275 | + | substances detector who, in the ordinary course of such trainer’s or | |
276 | + | handler’s profession, desires to possess any controlled dange rous | |
277 | + | substance, annually, shall obtain a registration issued by the | |
278 | + | Director for a fee of Seventy Dollars ($70.00). Such persons shall | |
279 | + | ||
280 | + | ENGR. H. A. to ENGR. S. B. NO. 1943 Page 6 1 | |
281 | + | 2 | |
282 | + | 3 | |
283 | + | 4 | |
284 | + | 5 | |
285 | + | 6 | |
286 | + | 7 | |
287 | + | 8 | |
288 | + | 9 | |
289 | + | 10 | |
290 | + | 11 | |
291 | + | 12 | |
292 | + | 13 | |
293 | + | 14 | |
294 | + | 15 | |
295 | + | 16 | |
296 | + | 17 | |
297 | + | 18 | |
298 | + | 19 | |
299 | + | 20 | |
300 | + | 21 | |
301 | + | 22 | |
302 | + | 23 | |
303 | + | 24 | |
304 | + | ||
305 | + | be subject to all applicable provisions of Section 2 -101 et seq. of | |
306 | + | this title and such applicable rules promulgated by the Director for | |
307 | + | those individuals ident ified in subparagraph a of paragraph 32 of | |
308 | + | Section 2-101 of this title. Persons registered by the Director | |
309 | + | pursuant to this subsection may possess controlled dangerous | |
310 | + | substances to the extent authorized by their re gistration and in | |
311 | + | conformity with the ot her provisions of the Uniform Controlled | |
312 | + | Dangerous Substances Act. | |
313 | + | H. The following persons shall not be required to register and | |
314 | + | may lawfully possess controlled dangerous substances under the | |
315 | + | provisions of Section 2-101 et seq. of this title: | |
316 | + | 1. An agent, or an employee thereof, of any registered | |
317 | + | manufacturer, distributor, dispenser or user for scientific purposes | |
318 | + | of any controlled dangerous substance, if such agent is acting in | |
319 | + | the usual course of such agent’s or employee’s business or | |
320 | + | employment; | |
321 | + | 2. Any person lawfully acting under the direction of a person | |
322 | + | authorized to administer controlled dangerous substances under | |
323 | + | Section 2-312 of this title; | |
324 | + | 3. A common or contract carrier or warehouser, or an employee | |
325 | + | thereof, whose possession of any controlled dangerous substance is | |
326 | + | in the usual course of such carrier’s or warehouser’s business or | |
327 | + | employment; | |
328 | + | ||
329 | + | ENGR. H. A. to ENGR. S. B. NO. 1943 Page 7 1 | |
330 | + | 2 | |
331 | + | 3 | |
332 | + | 4 | |
333 | + | 5 | |
334 | + | 6 | |
335 | + | 7 | |
336 | + | 8 | |
337 | + | 9 | |
338 | + | 10 | |
339 | + | 11 | |
340 | + | 12 | |
341 | + | 13 | |
342 | + | 14 | |
343 | + | 15 | |
344 | + | 16 | |
345 | + | 17 | |
346 | + | 18 | |
347 | + | 19 | |
348 | + | 20 | |
349 | + | 21 | |
350 | + | 22 | |
351 | + | 23 | |
352 | + | 24 | |
353 | + | ||
354 | + | 4. An ultimate user or a person in possession of any controlled | |
355 | + | dangerous substance pursuant to a lawful order of a practitioner; | |
356 | + | 5. An individual pharm acist acting in the usual course of such | |
357 | + | pharmacist’s employment with a pharmacy registered pursuant to the | |
358 | + | provisions of Section 2 -101 et seq. of this title; | |
359 | + | 6. A nursing home licensed by this state; | |
360 | + | 7. Any Department of Mental Health and Substance Abus e Services | |
361 | + | employee or any person whose facility contracts with the Department | |
362 | + | of Mental Health and Substance Abuse Services whose possession of | |
363 | + | any dangerous drug, as defined in Section 353.1 of Title 59 of the | |
364 | + | Oklahoma Statutes, is for the purpose of del ivery of a mental health | |
365 | + | consumer’s medicine to the consumer’s home or residence; | |
366 | + | 8. Registered nurses and licensed practical nurses; and | |
367 | + | 9. An assisted living facility licensed by this state. | |
368 | + | I. The Director may, by rule, waive the requirement for | |
369 | + | registration or fee for registration of certain manufacturers, | |
370 | + | distributors, dispensers, prescribers, administrators or users for | |
371 | + | scientific purposes if the Director finds it consistent with the | |
372 | + | public health and safety. | |
373 | + | J. A separate registration shall be re quired at each principal | |
374 | + | place of business or professional practice where the applicant | |
375 | + | manufactures, distributes, dispenses, prescribes, administers or | |
376 | + | uses for scientific purposes controlled dangerous substances. | |
377 | + | ||
378 | + | ENGR. H. A. to ENGR. S. B. NO. 1943 Page 8 1 | |
379 | + | 2 | |
380 | + | 3 | |
381 | + | 4 | |
382 | + | 5 | |
383 | + | 6 | |
384 | + | 7 | |
385 | + | 8 | |
386 | + | 9 | |
387 | + | 10 | |
388 | + | 11 | |
389 | + | 12 | |
390 | + | 13 | |
391 | + | 14 | |
392 | + | 15 | |
393 | + | 16 | |
394 | + | 17 | |
395 | + | 18 | |
396 | + | 19 | |
397 | + | 20 | |
398 | + | 21 | |
399 | + | 22 | |
400 | + | 23 | |
401 | + | 24 | |
402 | + | ||
403 | + | K. The Director is authorized to inspect the establishment of a | |
404 | + | registrant or applicant for registration in accordance with rules | |
405 | + | promulgated by the Director. | |
406 | + | L. No person engaged in a profession or occupation for which a | |
407 | + | license to engage in such activit y is provided by law shall be | |
408 | + | registered under the Uniform Controlled Dangerous Substances Act | |
409 | + | unless such person holds a valid license of such person’s profession | |
410 | + | or occupation. | |
411 | + | M. Registrations shall be issued on the first day of November | |
412 | + | of each year and shall expire annually . Registrations may be issued | |
413 | + | at other times, however, upon certification of the professional | |
414 | + | licensing board. Registration applications shall be required | |
415 | + | annually thereafter. | |
416 | + | N. The licensing boards of all professions and occupa tions to | |
417 | + | which the use of controlled dan gerous substances is incidental shall | |
418 | + | furnish a current list to the Director, not later than the first day | |
419 | + | of October of each year, of the persons holding valid licenses. All | |
420 | + | such persons except persons exempt from registration requirements | |
421 | + | under subsection H of this section shall be subject to the | |
422 | + | registration requirements of Section 2 -101 et seq. of this title. | |
423 | + | O. The licensing board of any professional defined as a mid - | |
424 | + | level practitioner shall notify and furnish to the Director, not | |
425 | + | later than the first day of October of each year, that such | |
426 | + | professional holds a valid license, a current listing of individuals | |
427 | + | ||
428 | + | ENGR. H. A. to ENGR. S. B. NO. 1943 Page 9 1 | |
429 | + | 2 | |
430 | + | 3 | |
431 | + | 4 | |
432 | + | 5 | |
433 | + | 6 | |
434 | + | 7 | |
435 | + | 8 | |
436 | + | 9 | |
437 | + | 10 | |
438 | + | 11 | |
439 | + | 12 | |
440 | + | 13 | |
441 | + | 14 | |
442 | + | 15 | |
443 | + | 16 | |
444 | + | 17 | |
445 | + | 18 | |
446 | + | 19 | |
447 | + | 20 | |
448 | + | 21 | |
449 | + | 22 | |
450 | + | 23 | |
451 | + | 24 | |
452 | + | ||
453 | + | licensed and registered with their respective boards to prescribe, | |
454 | + | order, select, obtain and administer co ntrolled dangerous | |
455 | + | substances. The lice nsing board shall immediately notify the | |
456 | + | Director of any action subsequently taken against any such | |
457 | + | individual. | |
458 | + | P. Beginning November 1, 2010, each registrant that prescribes, | |
459 | + | administers or dispenses methadone shal l be required to check the | |
460 | + | prescription profile of the patient on the central repository of the | |
461 | + | Oklahoma State Bureau of Narcotics and Dangerous Drugs Control. | |
462 | + | Q. All legal entities applying for or approved for registration | |
463 | + | shall disclose to the Director all beneficial owners of the legal | |
464 | + | entity. Publicly traded entities shall be exempt from full | |
465 | + | disclosure; provided that, the publicly traded entity discloses to | |
466 | + | the Director all beneficial owners who exercise authority or control | |
467 | + | over controlled dangerous substances at each registered location . | |
468 | + | R. No registration, or any authority conferred thereby, shall | |
469 | + | be leased, assigned, or otherwise transferred. No registration | |
470 | + | shall be transferrable on change of ownership or business activity. | |
471 | + | SECTION 2. AMENDATORY 63 O.S. 2021 , Section 2-303, as | |
472 | + | amended by Section 1, Chapter 31, 1st Extraordinary Session, O.S.L. | |
473 | + | 2023 (63 O.S. Supp. 2023, Section 2 -303), is amended to read as | |
474 | + | follows: | |
475 | + | Section 2-303. A. The Director of the Oklahoma State Bureau of | |
476 | + | Narcotics and Dangerous Drugs Control shall register an applicant to | |
477 | + | ||
478 | + | ENGR. H. A. to ENGR. S. B. NO. 1943 Page 10 1 | |
479 | + | 2 | |
480 | + | 3 | |
481 | + | 4 | |
482 | + | 5 | |
483 | + | 6 | |
484 | + | 7 | |
485 | + | 8 | |
486 | + | 9 | |
487 | + | 10 | |
488 | + | 11 | |
489 | + | 12 | |
490 | + | 13 | |
491 | + | 14 | |
492 | + | 15 | |
493 | + | 16 | |
494 | + | 17 | |
495 | + | 18 | |
496 | + | 19 | |
497 | + | 20 | |
498 | + | 21 | |
499 | + | 22 | |
500 | + | 23 | |
501 | + | 24 | |
502 | + | ||
503 | + | own a medical facility as described in subsection C of Section 2 -302 | |
504 | + | of this title, or to manufacture, distribute, dispense, prescribe, | |
505 | + | administer or use for scientific purposes controlled dangerous | |
506 | + | substances included in Schedules I through V of Section 2 -101 et | |
507 | + | seq. of this title unless the Director determines that the issuance | |
508 | + | of such registration is inconsistent with the public interest. In | |
509 | + | determining the public interest, t he following factors shall be | |
510 | + | considered: | |
511 | + | 1. Maintenance of effective controls against diversion of | |
512 | + | particular controlled dangerous substances and any Schedule I or II | |
513 | + | substance compounded therefrom into other than legitimate medical, | |
514 | + | scientific or indust rial channels including examination of t he | |
515 | + | fitness of his or her employees or agents to handle dangerous | |
516 | + | substances; | |
517 | + | 2. Compliance with applicable state and local law; | |
518 | + | 3. Has been found guilty of, entered a plea of guilty or nolo | |
519 | + | contendere to a charge u nder the Uniform Controlled Dangerous | |
520 | + | Substances Act or any other state or federal law relating to any | |
521 | + | substance defined herein as a controlled dangerous substance or any | |
522 | + | felony under the laws of any state or the United States; | |
523 | + | 4. Furnishing by the applic ant false or fraudulent material | |
524 | + | information in any application filed under Section 2 -101 et seq. of | |
525 | + | this title; | |
526 | + | ||
527 | + | ENGR. H. A. to ENGR. S. B. NO. 1943 Page 11 1 | |
528 | + | 2 | |
529 | + | 3 | |
530 | + | 4 | |
531 | + | 5 | |
532 | + | 6 | |
533 | + | 7 | |
534 | + | 8 | |
535 | + | 9 | |
536 | + | 10 | |
537 | + | 11 | |
538 | + | 12 | |
539 | + | 13 | |
540 | + | 14 | |
541 | + | 15 | |
542 | + | 16 | |
543 | + | 17 | |
544 | + | 18 | |
545 | + | 19 | |
546 | + | 20 | |
547 | + | 21 | |
548 | + | 22 | |
549 | + | 23 | |
550 | + | 24 | |
551 | + | ||
552 | + | 5. Past experience in the manufacture, distribution, | |
553 | + | dispensing, prescribing, administering or use for scientific | |
554 | + | purposes of controlled dange rous substances, and the existence in | |
555 | + | the establishment of effective controls against diversion; | |
556 | + | 6. Denial, suspension or revocation of the applicant’s federal | |
557 | + | registration to manufacture, distribute or dispense controlled | |
558 | + | dangerous substances as authoriz ed by federal law; and | |
559 | + | 7. Such other factors as may be relevant to and consistent with | |
560 | + | the public health and safety. | |
561 | + | Nothing herein shall be deemed to require individual licensed | |
562 | + | pharmacists to register under the provisions of the Uniform | |
563 | + | Controlled Dangerous Substances Act. | |
564 | + | B. Registration granted under subsection A of this section | |
565 | + | shall not entitle a registrant to manufacture, distribute, dispense, | |
566 | + | prescribe, administer or use for scientific purposes controlled | |
567 | + | dangerous substances in Schedule I or II o ther than those specified | |
568 | + | in the registration. | |
569 | + | C. Practitioners shall be registered to dispense, prescribe, | |
570 | + | administer or use for scientific purposes substances in Schedules II | |
571 | + | through V if they are authorized to carry on their respective | |
572 | + | activities under the laws of this state. A registration application | |
573 | + | by a practitioner who wishes to conduct research with Schedule I | |
574 | + | substances shall be accompanied by evidence of the applicant’s | |
575 | + | federal registration to conduct such activity and shall be referred | |
576 | + | ||
577 | + | ENGR. H. A. to ENGR. S. B. NO. 1943 Page 12 1 | |
578 | + | 2 | |
579 | + | 3 | |
580 | + | 4 | |
581 | + | 5 | |
582 | + | 6 | |
583 | + | 7 | |
584 | + | 8 | |
585 | + | 9 | |
586 | + | 10 | |
587 | + | 11 | |
588 | + | 12 | |
589 | + | 13 | |
590 | + | 14 | |
591 | + | 15 | |
592 | + | 16 | |
593 | + | 17 | |
594 | + | 18 | |
595 | + | 19 | |
596 | + | 20 | |
597 | + | 21 | |
598 | + | 22 | |
599 | + | 23 | |
600 | + | 24 | |
601 | + | ||
602 | + | to the Medical Research Commission for advice. The Medical Research | |
603 | + | Commission shall promptly advise the Director concerning the | |
604 | + | qualifications of each practitioner requesting such registration. | |
605 | + | Registration for the purpose of bona fide research or of use for | |
606 | + | scientific purposes with Schedule I subst ances by a practitioner | |
607 | + | deemed qualified by the Medical Research Commission may be denied | |
608 | + | only on a ground specified in subsection A of Section 2 -304 of this | |
609 | + | title or if there are reasonable grounds to believe that t he | |
610 | + | applicant will abuse or unlawfully tr ansfer such substances or fail | |
611 | + | to safeguard adequately such applicant’s supply of such substances | |
612 | + | against diversion from legitimate medical or scientific use. | |
613 | + | D. 1. The Director shall initially permit persons to re gister | |
614 | + | who own or operate any establishm ent engaged in the manufacture, | |
615 | + | distribution, dispensing, prescribing, administering or use for | |
616 | + | scientific purposes of any controlled dangerous substances prior to | |
617 | + | June 4, 1991, and who are registered or licensed by the state. Fees | |
618 | + | for registration under this section shall be as follows: | |
619 | + | Practitioners and mid -level | |
620 | + | practitioners $140.00 per year | |
621 | + | of registration | |
622 | + | Home Care Agencies, Hospices & | |
623 | + | Home Care Services $140.00 annually | |
624 | + | Medical Facility Owners $300.00 annually | |
625 | + | Distributors $300.00 annually | |
626 | + | ||
627 | + | ENGR. H. A. to ENGR. S. B. NO. 1943 Page 13 1 | |
628 | + | 2 | |
629 | + | 3 | |
630 | + | 4 | |
631 | + | 5 | |
632 | + | 6 | |
633 | + | 7 | |
634 | + | 8 | |
635 | + | 9 | |
636 | + | 10 | |
637 | + | 11 | |
638 | + | 12 | |
639 | + | 13 | |
640 | + | 14 | |
641 | + | 15 | |
642 | + | 16 | |
643 | + | 17 | |
644 | + | 18 | |
645 | + | 19 | |
646 | + | 20 | |
647 | + | 21 | |
648 | + | 22 | |
649 | + | 23 | |
650 | + | 24 | |
651 | + | ||
652 | + | Manufacturers $2,500.00 annually | |
653 | + | Manufacturer, Wholesaler, or | |
654 | + | Distributor of drug products | |
655 | + | containing pseudoephedrine | |
656 | + | or phenylpropanolamine $300.00 annually | |
657 | + | 2. A registrant shall be required to pay double the amount of | |
658 | + | the above-listed fee for any renewal of reg istration received more | |
659 | + | than thirty (30) days late. | |
660 | + | 3. A Ten Dollar ($10.00) fee shall be charged for a duplicate | |
661 | + | registration certificate. | |
662 | + | E. Compliance by manufacturers and distributors with the | |
663 | + | provisions of the Federal federal Controlled Substances A ct, 21 | |
664 | + | U.S.C., Section 801 et seq., respecting registration, excluding | |
665 | + | fees, shall be deemed sufficient to qualify for registration under | |
666 | + | Section 2-101 et seq. of this title. | |
667 | + | F. Applications for renewal of registrat ion shall open on the | |
668 | + | first day of July annually. Applications for renewal shall be | |
669 | + | considered timely if submitted by the first day of September | |
670 | + | annually. Registrations not renewed by the final day of any | |
671 | + | calendar year in which the registration was issue d shall be | |
672 | + | ineligible for renewal and sh all require a new registration upon | |
673 | + | return to the Bureau. With notice provided prior to expiration, the | |
674 | + | Director may waive the requirement of a new registration pursuant to | |
675 | + | promulgated rules. New applications with substantive changes to the | |
676 | + | ||
677 | + | ENGR. H. A. to ENGR. S. B. NO. 1943 Page 14 1 | |
678 | + | 2 | |
679 | + | 3 | |
680 | + | 4 | |
681 | + | 5 | |
682 | + | 6 | |
683 | + | 7 | |
684 | + | 8 | |
685 | + | 9 | |
686 | + | 10 | |
687 | + | 11 | |
688 | + | 12 | |
689 | + | 13 | |
690 | + | 14 | |
691 | + | 15 | |
692 | + | 16 | |
693 | + | 17 | |
694 | + | 18 | |
695 | + | 19 | |
696 | + | 20 | |
697 | + | 21 | |
698 | + | 22 | |
699 | + | 23 | |
700 | + | 24 | |
701 | + | ||
702 | + | original registration shall not be considered a transfer of any | |
703 | + | activity of a continuing nature. | |
704 | + | SECTION 3. This act shall become effective November 1, 2024. " | |
705 | + | Passed the House of Representatives the 23rd day of April, 2024. | |
706 | + | ||
707 | + | ||
708 | + | ||
709 | + | ||
710 | + | ||
711 | + | Presiding Officer of the House of | |
712 | + | Representatives | |
713 | + | ||
714 | + | ||
715 | + | Passed the Senate the ____ day of _______ ___, 2024. | |
716 | + | ||
717 | + | ||
718 | + | ||
719 | + | ||
720 | + | ||
721 | + | Presiding Officer of the Senate | |
722 | + | ||
723 | + | ENGR. S. B. NO. 1943 Page 1 1 | |
724 | + | 2 | |
725 | + | 3 | |
726 | + | 4 | |
727 | + | 5 | |
728 | + | 6 | |
729 | + | 7 | |
730 | + | 8 | |
731 | + | 9 | |
732 | + | 10 | |
733 | + | 11 | |
734 | + | 12 | |
735 | + | 13 | |
736 | + | 14 | |
737 | + | 15 | |
738 | + | 16 | |
739 | + | 17 | |
740 | + | 18 | |
741 | + | 19 | |
742 | + | 20 | |
743 | + | 21 | |
744 | + | 22 | |
745 | + | 23 | |
746 | + | 24 | |
747 | + | ||
748 | + | ENGROSSED SENATE | |
749 | + | BILL NO. 1943 By: Paxton of the Senate | |
750 | + | ||
751 | + | and | |
752 | + | ||
753 | + | Pfeiffer of the House | |
754 | + | ||
755 | + | ||
756 | + | ||
757 | + | ||
758 | + | An Act relating to the Uniform Controlled Dangerous | |
759 | + | Substances Act; amending 63 O.S. 2021, Section 2 -302, | |
760 | + | as amended by Section 1, Chapter 103, O.S.L. 2023 (63 | |
761 | + | O.S. Supp. 2023, Section 2 -302), which relates to | |
762 | + | registration requirements; setting expiration of | |
763 | + | registration and requirement for application | |
764 | + | annually; requiring certain disclosure at | |
765 | + | application; providing exception; prohibiting | |
766 | + | transfer of registration; a mending 63 O.S. 2021, | |
767 | + | Section 2-303, as amended by Section 1, Chapter 31, | |
768 | + | 1st Extraordinary Session, O.S.L. 2023 (63 O.S. Supp. | |
769 | + | 2023, Section 2-303), which relates to registration; | |
770 | + | removing ability for persons to be initially | |
771 | + | permitted and certain fees ass ociated with | |
772 | + | registration; providing for promulgation of rules; | |
773 | + | updating statutory language; and providing an | |
774 | + | effective date. | |
775 | + | ||
776 | + | ||
777 | + | ||
778 | + | ||
779 | + | ||
780 | + | BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: | |
781 | + | SECTION 4. AMENDATORY 63 O.S. 2021, Section 2 -302, as | |
782 | + | amended by Section 1, Chapter 103, O.S.L. 2023 (63 O.S. Supp. 2023, | |
783 | + | Section 2-302), is amended to read as follows: | |
44 | 784 | Section 2-302. A. Every person who manufactures, distributes, | |
45 | 785 | dispenses, prescribes, administers or uses for scientific purposes | |
46 | 786 | any controlled dangerous substance within or into this state, or who | |
47 | 787 | proposes to engage in the m anufacture, distribution, disp ensing, | |
48 | 788 | ||
49 | - | ENR. S. B. NO. 1943 Page 2 | |
789 | + | ENGR. S. B. NO. 1943 Page 2 1 | |
790 | + | 2 | |
791 | + | 3 | |
792 | + | 4 | |
793 | + | 5 | |
794 | + | 6 | |
795 | + | 7 | |
796 | + | 8 | |
797 | + | 9 | |
798 | + | 10 | |
799 | + | 11 | |
800 | + | 12 | |
801 | + | 13 | |
802 | + | 14 | |
803 | + | 15 | |
804 | + | 16 | |
805 | + | 17 | |
806 | + | 18 | |
807 | + | 19 | |
808 | + | 20 | |
809 | + | 21 | |
810 | + | 22 | |
811 | + | 23 | |
812 | + | 24 | |
813 | + | ||
50 | 814 | prescribing, administering or use for scientific purposes of any | |
51 | 815 | controlled dangerous substance within or into this state s hall | |
52 | 816 | obtain a registration issued by the Director of the Oklahoma State | |
53 | 817 | Bureau of Narcotics and Dangerous Drugs Control, in accordance with | |
54 | 818 | rules promulgated by the Director. Persons registered by the | |
55 | 819 | Director under Section 2 -101 et seq. of this title to manufacture, | |
56 | 820 | distribute, dispense or conduct research with controlled dangerous | |
57 | 821 | substances may possess, manufacture, distribu te, dispense or conduct | |
58 | 822 | research with those substances to the extent authorized by their | |
59 | 823 | registration and in conformity with the ot her provisions of the | |
60 | 824 | Uniform Controlled Dangerous Substances Act. Every wholesaler, | |
61 | 825 | manufacturer or distributor of any drug product containing | |
62 | 826 | pseudoephedrine or phenylpropanolamine, or their salts, isomers or | |
63 | 827 | salts of isomers, shall obtain a registratio n issued by the Director | |
64 | 828 | of the Oklahoma State Bureau of Narcotics and Dangerous Drugs | |
65 | 829 | Control in accordance with rules promu lgated by the Director and as | |
66 | 830 | provided for in Section 2 -332 of this title. Any person who | |
67 | 831 | manufactures, distributes, dispenses, pr escribes, administers or | |
68 | 832 | uses for scientific purposes any controlled dangerous substances | |
69 | 833 | within or into this state without first obtaining a registration | |
70 | 834 | issued by the Director of the Oklahoma State Bureau of Narcotics and | |
71 | 835 | Dangerous Drugs Control shall be subject to the same statutory and | |
72 | 836 | administrative jurisdiction of the Director as if that perso n were | |
73 | 837 | an applicant or registr ant. | |
74 | 838 | ||
839 | + | ENGR. S. B. NO. 1943 Page 3 1 | |
840 | + | 2 | |
841 | + | 3 | |
842 | + | 4 | |
843 | + | 5 | |
844 | + | 6 | |
845 | + | 7 | |
846 | + | 8 | |
847 | + | 9 | |
848 | + | 10 | |
849 | + | 11 | |
850 | + | 12 | |
851 | + | 13 | |
852 | + | 14 | |
853 | + | 15 | |
854 | + | 16 | |
855 | + | 17 | |
856 | + | 18 | |
857 | + | 19 | |
858 | + | 20 | |
859 | + | 21 | |
860 | + | 22 | |
861 | + | 23 | |
862 | + | 24 | |
863 | + | ||
75 | 864 | B. Out-of-state pharmaceutical suppliers who provide controlled | |
76 | 865 | dangerous substances to individuals within this state shall o btain a | |
77 | 866 | registration issued by the Director of the Oklahoma State Bureau of | |
78 | 867 | Narcotics and Dangerous Drugs Control, in accordance with rules | |
79 | 868 | promulgated by the Director. This provision shall also apply to | |
80 | 869 | wholesale distributors who distribute controlled da ngerous | |
81 | 870 | substances to pharmacies or other entities registered within this | |
82 | 871 | state in accordance w ith rules promulgated by the D irector. | |
83 | - | ||
84 | 872 | C. Every person who owns in whole or in part a public or | |
85 | 873 | private medical facility for which a majority of patients are is sued | |
86 | 874 | on a reoccurring monthly basis a prescription for opioids, | |
87 | 875 | benzodiazepines, barbiturates o r carisoprodol, but not including | |
88 | 876 | buprenorphine with naloxone or buprenorphine as used for medication- | |
89 | 877 | assisted treatment services, shall obtain a registration is sued by | |
90 | 878 | the Director of the Oklahoma State Bureau of Narcotics and Dangerous | |
91 | 879 | Drugs Control. | |
92 | - | ||
93 | - | ENR. S. B. NO. 1943 Page 3 | |
94 | - | ||
95 | 880 | D. Every manufacturer and distri butor required to register | |
96 | 881 | under the provisions of this section shall provide all data required | |
97 | 882 | pursuant to 21 U.S.C., Section 827( d)(1) on a monthly basis to the | |
98 | 883 | Oklahoma State Bureau of Narcotics and Dangerous Drugs Control. | |
99 | 884 | Controlled dangerous substances in Schedule I shall be reported in | |
100 | 885 | accordance with rules promulgated by the Director. Reporting of | |
101 | 886 | controlled dangerous substa nces pursuant to 21 U.S.C., Section | |
102 | 887 | 827(d)(1) shall include, but not be limited to: | |
103 | 888 | ||
889 | + | ENGR. S. B. NO. 1943 Page 4 1 | |
890 | + | 2 | |
891 | + | 3 | |
892 | + | 4 | |
893 | + | 5 | |
894 | + | 6 | |
895 | + | 7 | |
896 | + | 8 | |
897 | + | 9 | |
898 | + | 10 | |
899 | + | 11 | |
900 | + | 12 | |
901 | + | 13 | |
902 | + | 14 | |
903 | + | 15 | |
904 | + | 16 | |
905 | + | 17 | |
906 | + | 18 | |
907 | + | 19 | |
908 | + | 20 | |
909 | + | 21 | |
910 | + | 22 | |
911 | + | 23 | |
912 | + | 24 | |
913 | + | ||
104 | 914 | 1. The manufacturer’s or distributor’s name, address, phone | |
105 | 915 | number, DEA registration number and controlled dangerous substance | |
106 | 916 | registration number issued by the Bureau; | |
107 | - | ||
108 | 917 | 2. The name, address and DEA registration number of the entity | |
109 | 918 | to whom the controlled dangerous substance was sold; | |
110 | - | ||
111 | 919 | 3. The date of the sale of the controlled dangerous substance; | |
112 | - | ||
113 | 920 | 4. The name and National Drug Code of the controlled dangerous | |
114 | 921 | substance sold; and | |
115 | - | ||
116 | 922 | 5. The number of containers and the strength and quantity of | |
117 | 923 | controlled dangerous subst ances in each container sold. | |
118 | - | ||
119 | 924 | E. The information maintained and provided pursuant to | |
120 | 925 | subsection D of this section shall be confidential and not open to | |
121 | 926 | the public. Access to the information shall, at the discretion of | |
122 | 927 | the Director, be limited to: | |
123 | - | ||
124 | 928 | 1. Peace officers certified pursuant to the provisions of | |
125 | 929 | Section 3311 of Title 70 of the Oklahoma Statutes who are employed | |
126 | 930 | as investigative agents of the Oklahoma St ate Bureau of Narcotics | |
127 | 931 | and Dangerous Drugs Control or the Office of the Attorney General; | |
128 | - | ||
129 | 932 | 2. The United States Drug Enforce ment Administration Diversion | |
130 | 933 | Group Supervisor; and | |
131 | - | ||
132 | 934 | 3. A multicounty grand jury properly convened pursuant to the | |
133 | 935 | provisions of the Multicounty Grand Jury Act. | |
134 | - | ||
135 | - | ||
136 | - | ENR. S. B. NO. 1943 Page 4 | |
137 | 936 | F. Manufacturers, distributors, home care agencies, hospices, | |
138 | 937 | home care services, medical facility owners referred to in | |
938 | + | ||
939 | + | ENGR. S. B. NO. 1943 Page 5 1 | |
940 | + | 2 | |
941 | + | 3 | |
942 | + | 4 | |
943 | + | 5 | |
944 | + | 6 | |
945 | + | 7 | |
946 | + | 8 | |
947 | + | 9 | |
948 | + | 10 | |
949 | + | 11 | |
950 | + | 12 | |
951 | + | 13 | |
952 | + | 14 | |
953 | + | 15 | |
954 | + | 16 | |
955 | + | 17 | |
956 | + | 18 | |
957 | + | 19 | |
958 | + | 20 | |
959 | + | 21 | |
960 | + | 22 | |
961 | + | 23 | |
962 | + | 24 | |
963 | + | ||
139 | 964 | subsection C of this section and scientific researchers shall obtain | |
140 | 965 | a registration annually. Other pra ctitioners shall obtain a | |
141 | 966 | registration for a period to be determined by the Director that will | |
142 | 967 | be for a period not less than one (1) year nor more than three (3) | |
143 | 968 | years. | |
144 | - | ||
145 | 969 | G. Every trainer or handler of a canine controlled dangerous | |
146 | 970 | substances detector who, in the ordinary course of such trainer ’s or | |
147 | 971 | handler’s profession, desires to possess any contro lled dangerous | |
148 | 972 | substance, annually, shall obtain a registration issued by the | |
149 | 973 | Director for a fee of Seventy Dollars ($70.00). Such persons shall | |
150 | 974 | be subject to all applicable provisions of Section 2 -101 et seq. of | |
151 | 975 | this title and such applicable rules promu lgated by the Director for | |
152 | 976 | those individuals identified in subparagraph a of paragraph 32 of | |
153 | 977 | Section 2-101 of this title. Persons registered by the Director | |
154 | 978 | pursuant to this subsection may possess controlled dangerous | |
155 | 979 | substances to the extent authorized b y their registration and in | |
156 | 980 | conformity with the other provisions of the Uniform Controlled | |
157 | 981 | Dangerous Substances Act. | |
158 | - | ||
159 | 982 | H. The following persons shall not be requi red to register and | |
160 | 983 | may lawfully possess controlled dangerous substances under the | |
161 | 984 | provisions of Section 2-101 et seq. of this title: | |
162 | - | ||
163 | 985 | 1. An agent, or an employee thereof, of any registered | |
164 | 986 | manufacturer, distributor, dispenser or user for scientific purpos es | |
165 | 987 | of any controlled dangerous substance, if such agent is acting in | |
988 | + | ||
989 | + | ENGR. S. B. NO. 1943 Page 6 1 | |
990 | + | 2 | |
991 | + | 3 | |
992 | + | 4 | |
993 | + | 5 | |
994 | + | 6 | |
995 | + | 7 | |
996 | + | 8 | |
997 | + | 9 | |
998 | + | 10 | |
999 | + | 11 | |
1000 | + | 12 | |
1001 | + | 13 | |
1002 | + | 14 | |
1003 | + | 15 | |
1004 | + | 16 | |
1005 | + | 17 | |
1006 | + | 18 | |
1007 | + | 19 | |
1008 | + | 20 | |
1009 | + | 21 | |
1010 | + | 22 | |
1011 | + | 23 | |
1012 | + | 24 | |
1013 | + | ||
166 | 1014 | the usual course of such a gent’s or employee’s business or | |
167 | 1015 | employment; | |
168 | - | ||
169 | 1016 | 2. Any person lawfully acting under the direction of a person | |
170 | 1017 | authorized to administer controlled dangerous substan ces under | |
171 | 1018 | Section 2-312 of this title; | |
172 | - | ||
173 | 1019 | 3. A common or contract carrier or warehouser, or an em ployee | |
174 | 1020 | thereof, whose possessi on of any controlled dangerous substance is | |
175 | 1021 | in the usual course of such carrier ’s or warehouser’s business or | |
176 | 1022 | employment; | |
177 | - | ||
178 | - | ||
179 | - | ENR. S. B. NO. 1943 Page 5 | |
180 | 1023 | 4. An ultimate user or a person in possession of any controlled | |
181 | 1024 | dangerous substance pursuant to a lawfu l order of a practitioner; | |
182 | - | ||
183 | 1025 | 5. An individual pharmacist acting in the usual course of such | |
184 | 1026 | pharmacist’s employment with a pharmacy registered pursuant to the | |
185 | 1027 | provisions of Section 2 -101 et seq. of this title; | |
186 | - | ||
187 | 1028 | 6. A nursing home licensed by this state; | |
188 | - | ||
189 | 1029 | 7. Any Department of Mental Healt h and Substance Abuse Services | |
190 | 1030 | employee or any person whose facility contracts with the Department | |
191 | 1031 | of Mental Health and Substance A buse Services whose possession of | |
192 | 1032 | any dangerous drug, as defined in Section 353.1 of Title 59 o f the | |
193 | 1033 | Oklahoma Statutes, is for the purpose of delivery of a mental health | |
194 | 1034 | consumer’s medicine to the consumer ’s home or residence; | |
1035 | + | 8. Registered nurses and lic ensed practical nurses; and | |
1036 | + | 9. An assisted living facility licensed by this state. | |
195 | 1037 | ||
196 | - | 8. Registered nurses and licensed practical nurses; and | |
197 | - | ||
198 | - | 9. An assisted living facility licensed by this state. | |
1038 | + | ENGR. S. B. NO. 1943 Page 7 1 | |
1039 | + | 2 | |
1040 | + | 3 | |
1041 | + | 4 | |
1042 | + | 5 | |
1043 | + | 6 | |
1044 | + | 7 | |
1045 | + | 8 | |
1046 | + | 9 | |
1047 | + | 10 | |
1048 | + | 11 | |
1049 | + | 12 | |
1050 | + | 13 | |
1051 | + | 14 | |
1052 | + | 15 | |
1053 | + | 16 | |
1054 | + | 17 | |
1055 | + | 18 | |
1056 | + | 19 | |
1057 | + | 20 | |
1058 | + | 21 | |
1059 | + | 22 | |
1060 | + | 23 | |
1061 | + | 24 | |
199 | 1062 | ||
200 | 1063 | I. The Director may, by rule, waive the requirement for | |
201 | 1064 | registration or fee for registration of certain manufacturers, | |
202 | 1065 | distributors, dispensers, prescribers, administrator s or users for | |
203 | 1066 | scientific purposes if the Director finds it consistent with the | |
204 | 1067 | public health and safety. | |
205 | - | ||
206 | 1068 | J. A separate registration shall be required at each principal | |
207 | 1069 | place of business or professional practice where the applicant | |
208 | 1070 | manufactures, distribut es, dispenses, prescribes, administers or | |
209 | 1071 | uses for scientific purposes controlled dangerous sub stances. | |
210 | - | ||
211 | 1072 | K. The Director is a uthorized to inspect the establishment of a | |
212 | 1073 | registrant or applicant for registration in accordance with rules | |
213 | 1074 | promulgated by the Di rector. | |
214 | - | ||
215 | 1075 | L. No person engaged in a profession or occupation for which a | |
216 | 1076 | license to engage in su ch activity is provided by law shall be | |
217 | 1077 | registered under the Uniform Controlled Dangerous Substances Act | |
218 | 1078 | unless such person holds a valid license of such person ’s profession | |
219 | 1079 | or occupation. | |
220 | - | ||
221 | - | ||
222 | - | ENR. S. B. NO. 1943 Page 6 | |
223 | 1080 | M. Registrations shall be issued on the first day of November | |
224 | 1081 | of each year and shall expire annu ally. Registrations may be issued | |
225 | 1082 | at other times, however, upon certification of the professional | |
226 | 1083 | licensing board. Registration applications shall be required | |
227 | 1084 | annually thereafter. | |
228 | - | ||
229 | 1085 | N. The licensing boards of all professions and occupations to | |
230 | 1086 | which the use of controlled dangerous substances is incidental shall | |
1087 | + | ||
1088 | + | ENGR. S. B. NO. 1943 Page 8 1 | |
1089 | + | 2 | |
1090 | + | 3 | |
1091 | + | 4 | |
1092 | + | 5 | |
1093 | + | 6 | |
1094 | + | 7 | |
1095 | + | 8 | |
1096 | + | 9 | |
1097 | + | 10 | |
1098 | + | 11 | |
1099 | + | 12 | |
1100 | + | 13 | |
1101 | + | 14 | |
1102 | + | 15 | |
1103 | + | 16 | |
1104 | + | 17 | |
1105 | + | 18 | |
1106 | + | 19 | |
1107 | + | 20 | |
1108 | + | 21 | |
1109 | + | 22 | |
1110 | + | 23 | |
1111 | + | 24 | |
1112 | + | ||
231 | 1113 | furnish a current list to the Director, not later than the first day | |
232 | 1114 | of October of each year, of the persons holding valid licenses. All | |
233 | 1115 | such persons except persons ex empt from registration require ments | |
234 | 1116 | under subsection H of this section shall be subject to the | |
235 | 1117 | registration requirements of Section 2 -101 et seq. of this title. | |
236 | - | ||
237 | 1118 | O. The licensing board of any professional defined as a mid - | |
238 | 1119 | level practitioner shall notify an d furnish to the Director, not | |
239 | 1120 | later than the first day of October of each year, that such | |
240 | 1121 | professional holds a valid license, a current listing of individuals | |
241 | 1122 | licensed and registered with their respective boards to prescribe, | |
242 | 1123 | order, select, obtain and adm inister controlled dangerous | |
243 | 1124 | substances. The licensing board shall immediately notify the | |
244 | 1125 | Director of any action subsequently taken against any such | |
245 | 1126 | individual. | |
246 | - | ||
247 | 1127 | P. Beginning November 1, 2010, each registrant that prescribes, | |
248 | 1128 | administers or dispenses meth adone shall be required to check the | |
249 | 1129 | prescription profile of the patient on the central repository of the | |
250 | 1130 | Oklahoma State Bureau of Narcotics and Dangerous Drugs Control. | |
251 | - | ||
252 | 1131 | Q. All legal entities applying for or approved for registration | |
253 | 1132 | shall disclose to the Director all beneficial owner s of the legal | |
254 | - | entity. Publicly traded entities shall be exempt from full | |
255 | - | disclosure; provided that, the publicly traded entity discloses to | |
256 | - | the Director all beneficial owners who exercise authority or control | |
257 | - | over controlled dangerous substances at each registered location. | |
258 | - | ||
1133 | + | entity. Publicly traded entities shall be exempt from disclosure. | |
259 | 1134 | R. No registration, or any authority conferred t hereby, shall | |
260 | 1135 | be leased, assigned, or otherwise transferred. No registration | |
261 | 1136 | shall be transferrable on change of ownership or business activity. | |
262 | 1137 | ||
263 | - | SECTION 2. AMENDATORY 63 O.S. 2021, Sect ion 2-303, as | |
1138 | + | ENGR. S. B. NO. 1943 Page 9 1 | |
1139 | + | 2 | |
1140 | + | 3 | |
1141 | + | 4 | |
1142 | + | 5 | |
1143 | + | 6 | |
1144 | + | 7 | |
1145 | + | 8 | |
1146 | + | 9 | |
1147 | + | 10 | |
1148 | + | 11 | |
1149 | + | 12 | |
1150 | + | 13 | |
1151 | + | 14 | |
1152 | + | 15 | |
1153 | + | 16 | |
1154 | + | 17 | |
1155 | + | 18 | |
1156 | + | 19 | |
1157 | + | 20 | |
1158 | + | 21 | |
1159 | + | 22 | |
1160 | + | 23 | |
1161 | + | 24 | |
1162 | + | ||
1163 | + | SECTION 5. AMENDATORY 63 O.S. 2021, Section 2 -303, as | |
264 | 1164 | amended by Section 1, Chapter 31, 1st Extraordinary Session, O.S.L. | |
265 | - | ||
266 | - | ENR. S. B. NO. 1943 Page 7 | |
267 | 1165 | 2023 (63 O.S. Supp. 2023, Section 2 -303), is amended to r ead as | |
268 | 1166 | follows: | |
269 | - | ||
270 | 1167 | Section 2-303. A. The Director of the Oklahoma State Bureau of | |
271 | 1168 | Narcotics and Dangerous Drugs Control shall register an applicant to | |
272 | 1169 | own a medical facility as described in subsection C of Section 2 -302 | |
273 | 1170 | of this title, or to manufacture, dis tribute, dispense, prescribe, | |
274 | 1171 | administer or use for scientific purposes controlled dangerous | |
275 | 1172 | substances included in Schedules I through V of Section 2 -101 et | |
276 | 1173 | seq. of this title unless the Director determines that the issuance | |
277 | 1174 | of such registration is incons istent with the public interes t. In | |
278 | 1175 | determining the public interest, the following factors shall be | |
279 | 1176 | considered: | |
280 | - | ||
281 | 1177 | 1. Maintenance of effective controls against di version of | |
282 | 1178 | particular controlled dangerous substances and any Schedule I or II | |
283 | 1179 | substance compounded therefrom into other than legitimate medical, | |
284 | 1180 | scientific or industrial channels including examination of the | |
285 | 1181 | fitness of his or her employees or agents to ha ndle dangerous | |
286 | 1182 | substances; | |
287 | - | ||
288 | 1183 | 2. Compliance with applicable state and local law; | |
289 | - | ||
290 | 1184 | 3. Has been found guilty of, entered a plea o f guilty or nolo | |
291 | 1185 | contendere to a charge under the Uniform Controlled Dangerous | |
292 | 1186 | Substances Act or any other state or federal law rel ating to any | |
1187 | + | ||
1188 | + | ENGR. S. B. NO. 1943 Page 10 1 | |
1189 | + | 2 | |
1190 | + | 3 | |
1191 | + | 4 | |
1192 | + | 5 | |
1193 | + | 6 | |
1194 | + | 7 | |
1195 | + | 8 | |
1196 | + | 9 | |
1197 | + | 10 | |
1198 | + | 11 | |
1199 | + | 12 | |
1200 | + | 13 | |
1201 | + | 14 | |
1202 | + | 15 | |
1203 | + | 16 | |
1204 | + | 17 | |
1205 | + | 18 | |
1206 | + | 19 | |
1207 | + | 20 | |
1208 | + | 21 | |
1209 | + | 22 | |
1210 | + | 23 | |
1211 | + | 24 | |
1212 | + | ||
293 | 1213 | substance defined herein as a controlled dangerous substance or any | |
294 | 1214 | felony under the laws of any state or the United States; | |
295 | - | ||
296 | 1215 | 4. Furnishing by the applicant false or fraudulent material | |
297 | 1216 | information in any application filed under Section 2 -101 et seq. of | |
298 | 1217 | this title; | |
299 | - | ||
300 | 1218 | 5. Past experience in the manufacture, distribution, | |
301 | 1219 | dispensing, prescribing, administering or use fo r scientific | |
302 | 1220 | purposes of controlled dangerous substances, and the existence in | |
303 | 1221 | the establishment of effective controls against dive rsion; | |
304 | - | ||
305 | 1222 | 6. Denial, suspension or revocation of the applicant ’s federal | |
306 | 1223 | registration to manufact ure, distribute or dispense controlled | |
307 | 1224 | dangerous substances as authorized by federal law; and | |
308 | - | ||
309 | - | ||
310 | - | ENR. S. B. NO. 1943 Page 8 | |
311 | 1225 | 7. Such other factors as may be relevant to and consistent with | |
312 | 1226 | the public health and safety. | |
313 | - | ||
314 | 1227 | Nothing herein shall be deemed to require individual licensed | |
315 | 1228 | pharmacists to register under the p rovisions of the Uniform | |
316 | 1229 | Controlled Dangerous Substances Act. | |
317 | - | ||
318 | 1230 | B. Registration granted under subsection A of this section | |
319 | 1231 | shall not entitle a registrant to manufacture, distribute, dispense, | |
320 | 1232 | prescribe, administer or use for sc ientific purposes controlled | |
321 | 1233 | dangerous substances in Schedule I or II other than those specified | |
322 | 1234 | in the registration. | |
323 | - | ||
324 | 1235 | C. Practitioners shall be registered to di spense, prescribe, | |
325 | 1236 | administer or use for scientific purposes substances in Schedules II | |
1237 | + | ||
1238 | + | ENGR. S. B. NO. 1943 Page 11 1 | |
1239 | + | 2 | |
1240 | + | 3 | |
1241 | + | 4 | |
1242 | + | 5 | |
1243 | + | 6 | |
1244 | + | 7 | |
1245 | + | 8 | |
1246 | + | 9 | |
1247 | + | 10 | |
1248 | + | 11 | |
1249 | + | 12 | |
1250 | + | 13 | |
1251 | + | 14 | |
1252 | + | 15 | |
1253 | + | 16 | |
1254 | + | 17 | |
1255 | + | 18 | |
1256 | + | 19 | |
1257 | + | 20 | |
1258 | + | 21 | |
1259 | + | 22 | |
1260 | + | 23 | |
1261 | + | 24 | |
1262 | + | ||
326 | 1263 | through V if they are authorized to c arry on their respective | |
327 | 1264 | activities under the laws of this state. A registration application | |
328 | 1265 | by a practitioner who wishes to condu ct research with Schedule I | |
329 | 1266 | substances shall be accompanied by evidence of the applicant ’s | |
330 | 1267 | federal registration to conduct such activity and shall be referred | |
331 | 1268 | to the Medical Research Commission for advice. The Medical Research | |
332 | 1269 | Commission shall promptly ad vise the Director concerning the | |
333 | 1270 | qualifications of each practitioner requesting such registrati on. | |
334 | 1271 | Registration for the purp ose of bona fide research or of use for | |
335 | 1272 | scientific purposes with Schedule I substances by a practitioner | |
336 | 1273 | deemed qualified by the Me dical Research Commission may be denied | |
337 | 1274 | only on a ground specified in subsection A of Section 2 -304 of this | |
338 | 1275 | title or if there are reasonable grounds to believe that the | |
339 | 1276 | applicant will abuse or unlawfully transfer such substances or fail | |
340 | 1277 | to safeguard adequately such applicant’s supply of such substances | |
341 | 1278 | against diversion from legitimate medical or sc ientific use. | |
342 | - | ||
343 | 1279 | D. 1. The Director shall initially permit persons to register | |
344 | 1280 | who own or operate any establishment engaged in the manufacture, | |
345 | 1281 | distribution, dispensing, prescribing, administering or use for | |
346 | 1282 | scientific purposes of any controlled dangerous s ubstances prior to | |
347 | 1283 | June 4, 1991, and who are registered or licensed by the state. Fees | |
348 | 1284 | for registration under this section shall be as follows: | |
349 | - | ||
350 | 1285 | Practitioners and mid-level | |
351 | 1286 | practitioners $140.00 per year | |
1287 | + | ||
1288 | + | ENGR. S. B. NO. 1943 Page 12 1 | |
1289 | + | 2 | |
1290 | + | 3 | |
1291 | + | 4 | |
1292 | + | 5 | |
1293 | + | 6 | |
1294 | + | 7 | |
1295 | + | 8 | |
1296 | + | 9 | |
1297 | + | 10 | |
1298 | + | 11 | |
1299 | + | 12 | |
1300 | + | 13 | |
1301 | + | 14 | |
1302 | + | 15 | |
1303 | + | 16 | |
1304 | + | 17 | |
1305 | + | 18 | |
1306 | + | 19 | |
1307 | + | 20 | |
1308 | + | 21 | |
1309 | + | 22 | |
1310 | + | 23 | |
1311 | + | 24 | |
1312 | + | ||
352 | 1313 | of registration | |
353 | - | ||
354 | - | ENR. S. B. NO. 1943 Page 9 | |
355 | - | ||
356 | 1314 | Home Care Agencies, Hospices & | |
357 | 1315 | Home Care Services $140.00 annually | |
358 | - | ||
359 | 1316 | Medical Facility Owners $300.00 annually | |
360 | - | ||
361 | 1317 | Distributors $300.00 annually | |
362 | - | ||
363 | 1318 | Manufacturers $2,500.00 annually | |
364 | - | ||
365 | 1319 | Manufacturer, Wholesaler, or | |
366 | 1320 | Distributor of drug products | |
367 | 1321 | containing pseudoephedrine | |
368 | 1322 | or phenylpropanolamine $300.00 annually | |
369 | - | ||
370 | 1323 | 2. A registrant shall be required to pay double the amount of | |
371 | 1324 | the above-listed fee for any renewal of registration received more | |
372 | 1325 | than thirty (30) days late . | |
373 | - | ||
374 | 1326 | 3. A Ten Dollar ($10.00) fee shall be charged for a duplicate | |
375 | 1327 | registration certificate. | |
376 | - | ||
377 | 1328 | E. Compliance by manufacturers an d distributors with the | |
378 | 1329 | provisions of the Federal federal Controlled Substances Act, 21 | |
379 | 1330 | U.S.C., Section 801 et seq., respecting reg istration, excluding | |
380 | 1331 | fees, shall be deemed sufficient to qualify for registration under | |
381 | 1332 | Section 2-101 et seq. of this title. | |
1333 | + | F. The Director shall promulgate rules necessary for | |
1334 | + | registration application periods. | |
1335 | + | SECTION 6. This act shall become effective November 1, 2024. | |
382 | 1336 | ||
383 | - | F. Applications for renewal of registration shall open on the | |
384 | - | first day of July annually. Applications for renewal shall be | |
385 | - | considered timely if submitted by the first day of September | |
386 | - | annually. Registrations not renewed by the final day of any | |
387 | - | calendar year in which the registration was issued shall be | |
388 | - | ineligible for renewal and shall require a new registration upon | |
389 | - | return to the Bureau. With notice provided prior to expiration, the | |
390 | - | Director may waive the requirement of a new registration pursuant to | |
391 | - | promulgated rules. New applications with substantive changes to t he | |
392 | - | original registration shall not be considered a transfer of any | |
393 | - | activity of a continuing nature. | |
1337 | + | ENGR. S. B. NO. 1943 Page 13 1 | |
1338 | + | 2 | |
1339 | + | 3 | |
1340 | + | 4 | |
1341 | + | 5 | |
1342 | + | 6 | |
1343 | + | 7 | |
1344 | + | 8 | |
1345 | + | 9 | |
1346 | + | 10 | |
1347 | + | 11 | |
1348 | + | 12 | |
1349 | + | 13 | |
1350 | + | 14 | |
1351 | + | 15 | |
1352 | + | 16 | |
1353 | + | 17 | |
1354 | + | 18 | |
1355 | + | 19 | |
1356 | + | 20 | |
1357 | + | 21 | |
1358 | + | 22 | |
1359 | + | 23 | |
1360 | + | 24 | |
394 | 1361 | ||
395 | - | SECTION 3. This act shall become effective November 1, 2024. | |
396 | - | ||
397 | - | ||
398 | - | ENR. S. B. NO. 1943 Page 10 | |
399 | - | Passed the Senate the 14th day of May, 2024. | |
1362 | + | Passed the Senate the 5th day of March, 2024. | |
400 | 1363 | ||
401 | 1364 | ||
402 | 1365 | ||
403 | 1366 | Presiding Officer of the Senate | |
404 | 1367 | ||
405 | 1368 | ||
406 | - | Passed the House of Representatives the 23rd day of April, 2024. | |
1369 | + | Passed the House of Representatives the ____ day of __________, | |
1370 | + | 2024. | |
407 | 1371 | ||
408 | 1372 | ||
409 | 1373 | ||
410 | 1374 | Presiding Officer of the House | |
411 | 1375 | of Representatives | |
412 | 1376 | ||
413 | - | OFFICE OF THE GOVERNOR | |
414 | - | Received by the Office of the Governor this _______ _____________ | |
415 | - | day of _________________ __, 20_______, at _______ o'clock _______ M. | |
416 | - | By: _________________________________ | |
417 | - | Approved by the Governor of the State of Oklahoma this _______ __ | |
418 | - | day of _________________ __, 20_______, at _______ o'clock _______ M. | |
419 | 1377 | ||
420 | - | _________________________________ | |
421 | - | Governor of the State of Oklahoma | |
422 | - | ||
423 | - | ||
424 | - | OFFICE OF THE SECRETARY OF STATE | |
425 | - | Received by the Office of the Secretary of State this _______ ___ | |
426 | - | day of _________________ _, 20 _______, at _______ o'clock _______ M. | |
427 | - | By: _________________________________ |